Cytochromes P-450, which in many organisms participate in the metabolism of a variety of endobiotic and xenobiotic substances, are synthesized by symbiotic bacteroids of Bradyrhizobium japonicum. Polyclonal antibodies were raised against two cytochromes P-450 (CYP112 and CYP114) purified from bacteroids. A lambda gtll expression clone ofB.japonicum USDA 110 DNA that reacted with the anti-CYP112 antibody was obtained and was used to screen a library of USDA 110 genomic DNA in pLAFRi for a clone of the P-450 locus.
Cytochromes P-450 mediate a wide variety of chemical reactions in animals, plants, and microbes, including enzymatic hydroxylation, demethylation, N oxidation, and reduction of some azo and nitro compounds (9) . Part of the chemical function of these P-450s is to bind and activate 02 for subsequent transfer to a substrate. Bradyrhizobium japonicum, the soybean microsymbiont, produces cytochromes P-450 both in the symbiotic state and in anaerobically cultured cells (1, 3, 7, 12) . The function of these bradyrhizobial P-450s is unknown, and no enzymatic activity has been discovered (3). However, P-450 may play a role in an efficient, oxyleghemoglobin-facilitated pathway of oxidative phosphorylation (4, 5, 26) .
Among the other N2-fixing bacteria, an Anabaena sp. contains a P-450-like sequence which interrupts the nifD gene (15) , and Agrobacterium tumefaciens contains two P-450-like open reading frames in a plant-inducible locus (11) , although none of the actual products of these genes have been identified or shown to be present during N2 fixation.
As the first step in elucidating the function of bradyrhizobial cytochromes P-450, cloning and mutagenesis of a locus of anaerobically and symbiotically expressed cytochrome P-450 genes from B. japonicum USDA 110 were performed, and the results are described in this paper. A mutant with a P-450-phenotype was symbiotically competent, indicating that P-450s are not involved in an essential symbiotic function.
MATERIALS AND METHODS
Bacterial strains, plasmids, phages, and growth. The strains, phages, and plasmids used in this study are listed in * Corresponding author. Table 1 . Escherichia coli was grown in Luria-Bertani medium or M9 minimal medium (16) supplemented with tetracycline (25 pg/ml) or ampicillin (50 ,ug/ml) for plasmid maintenance or with 40 ,ug of X-Gal (5-bromo-4-chloro-3-indolyl-p-D-galactopyranoside) per ml to indicate expression of lacZ reporter genes. An expression library of B. japonicum DNA in phage lambda gtll and a cosmid library in vector pLAFR1 have been described previously (23) .
B. japonicum was grown in AlE-gluconate medium (13) supplemented with kanamycin, streptomycin, and trimethoprim (100 ,ug/ml [each]) when needed for selection of the TnS mutant. Anaerobic cultures were grown in the same medium supplemented with 6 mM KNO3 (6 pearl TSK-gel butyl-650 M) equilibrated with column buffer containing 1 M ammonium sulfate. The column was eluted stepwise with 50-ml aliquots of column buffer containing decreasing concentrations of ammonium sulfate (1 to 0 M), and the fractions containing two different P-450s were collected. These P-450s were designated CYP112 and CYP114 by using standard nomenclature (17) . At this stage the partially purified P-450s obtained from the four separate extractions were pooled for final purification. The pooled fractions were rechromatographed with a column containing hydrophobic interaction medium. CYP112 purification. The CYP112-containing fractions were pooled, pressure concentrated to a small volume by using an Amicon Diaflo YM30 ultramembrane filter, and brought to a volume of 10 ml with DEAE column buffer, which contained 8 mM Tris in 20% [vol/vol] glycerol-0.1 mM EDTA-1 mM dithiothreitol and was adjusted to pH 7.5 with MES [2-(N-morpholino)ethanesulfonic acid]. The solution was applied to a DEAE-cellulose column (2.5 by 15 cm) equilibrated with the same buffer. The column was washed with buffer containing 0.1 M NaCl, and CYP112 (a brown band) was eluted by increasing the NaCl concentration in the eluent stepwise up to a concentration of 0.15 M. The solution was pressure concentrated to a volume of 1 ml and then subjected to size exclusion chromatography on a Fractogel TSK HW-55 column (0.9 by 161 cm) equilibrated with 10 mM sodium phosphate (pH 7.0) in 20% (vol/vol) glycerol-1 mM dithiothreitol-0.02% NaN3. The brown fraction containing CYP112 was eluted and applied to a column (0.7 by 16.5 cm) containing Prissm ceramic hydroxyapatite (Enprotech) buffered with 8 mM sodium phosphate (pH 7.0) in 20% (vol/vol) glycerol-80 ,uM CaCl2. CYP112, which only slightly adsorbed to the substrate, was eluted by increasing the concentration of phosphate in the column buffer to 30 mM. The eluted CYP112 was pressure concentrated to a small volume and stored at -20°C in 50% (vol/vol) glycerol. The preparation was judged to be essentially homogeneous on the basis of the results of sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) followed by silver staining (data not shown).
CYP114 purification. The crude CYP114 preparation was chromatographed on the Fractogel column as described above for CYP112. The CYP114 fractions were applied to a DEAE column (1.5 by 44 cm) and eluted with NaCl by increasing the concentration of NaCl in the eluent stepwise up to a concentration of 0.25 M. The brown fraction containing CYP114 was desalted by pressure concentration and subjected to preparative isoelectric focusing by using a Bio-Rad Rotofor isoelectric focusing cell and Bio-Lyte 3/10 ampholytes, as recommended by the manufacturer.
To further purify the CYP114 for antibody production, the protein was subjected to preparative gel electrophoresis and stained with Coomassie blue, and the blue-stained CYP114 band was excised and electroeluted.
Immunological procedures and Western blot (immunoblot) analysis. Polyclonal rabbit antisera were prepared against 1 mg of purified CYP112 and about 0.5 mg of CYP114 by Hazleton Research Products, Inc., Denver, Pa. Non-immunoglobulin-containing contaminants were removed from the serum by caprylic acid precipitation, followed by precipita- coli containing pRET61 (CYP112 gene, forward orientation), pRET60 (CYP112 gene, reverse orientation), and pRET74 (CYP114 gene, forward orientation), respectively. All B. japonicum lanes contained between 31 and 36 pg of total protein; all E. coli lanes contained the equivalent of 20 pll of cells from overnight LuriaBertani broth cultures. The numbers on the left indicate the positions molecular weight standards (x 103). The bands at approximately 45 kDa were presumed to be P-450 bands, since they comigrated with the purified protein bands in lanes A and B. The antibody used for the experiment shown in panel A contained contaminants that reacted with several constitutively expressed proteins in B. japonicum and E. coli strains and were apparently not related to the P-450 constructions. The bands in panel B at the lower tion of the immunoglobulin with ammonium sulfate at 50% saturation (22) . The antibodies were used to screen lambda gtll plaque lifts and to process Western blots of SDSpolyacrylamide gels as described previously (23) .
Recombinant DNA procedures. E. coli plasmids were isolated, digested with restriction enzymes, and used for cloning by using standard procedures (16) . The E. coli plasmid transformations were performed by the method of Hanahan (10) .
Plant growth and bacteroid isolation. Seeds of soybean (G. max cv. Williams) were sown in modified Leonard jars and inoculated with B. japonicum strains (23) . The plants were grown in a greenhouse under natural daylight conditions for 38 days. The plants were harvested, and their shoots were analyzed for dry mass and N content (25) . (Since shoot N content represents fixation integrated over a period of time, it is considered a better measure of N2 fixation than acetylene reduction, which is measured at only one or a few isolated time points.) Nodule number and mass also were determined. For Western blot analysis, bacteroids were extracted by grinding six nodules from each Leonard jar in 1 ml of 0.2 M sodium phosphate-1 mM EDTA (pH 7.0). The bacteroids were recovered by centrifugation at 16,000 x g with a microcentrifuge, boiled in 0.9 ml of Laemmli SDSmercaptoethanol treatment buffer, and subjected to SDS-PAGE (14) . A larger-scale isolation procedure to obtain a preparation for spectrophotometry was performed by using 10 g of nodules. The bacteroids were ruptured with the French pressure cell and ultracentrifuged for 1.5 h at 171,000 x g. The dark red membrane layer was resuspended in phosphate buffer. Soluble or membrane preparations were reduced with a few grains of sodium dithionite and treated with CO. Difference spectra ([reduced plus CO] minus reduced) were recorded with a Shimadzu model UV-3000 spectrophotometer operated in the dual-beam mode.
RESULTS
P-450 isolation. The CYP112 and CYP114 proteins were first resolved by hydrophobic interaction chromatography. They were judged to be separate and distinct proteins on the basis of their slightly different mobilities on SDS-polyacrylamide gels (although this is not clear in the Western blots shown in Fig. 1 , because the two gels were not run simultaneously). Thus, we inferred that these proteins probably are encoded by two separate genes. The fact that they are distinct proteins was confirmed by the specificities of the antibodies.
Antibody specificity. The anti-CYP112 antibody reacted with purified CYP112 (Fig. 1A, lane A) and with a polypeptide having the same mobility and presumed to be CYP112 in a cell-free bacteroid extract from USDA 110 (lane E) on a Western blot. A weak reaction with an extract obtained from anaerobically grown cells also was observed (lane D), but no reaction was seen with an extract obtained from aerobically grown cells (lane C). Similarly, the anti-CYP114 antibody reacted with purified CYP114 (Fig. 1B, grown cells (Fig. 1B, lanes C, D, and F, respectively) . The anti-CYP112 antibody did not react with purified CYP114 (Fig. 1A, lane B) , and the anti-CYP114 antibody did not react with purified CYP112 (Fig. 1B, lane A) . This confirms that CYP112 and CYP114 are different proteins that are expressed simultaneously in B. japonicum. The next step was to screen a library for one of the genes. The anti-CYP112 antibody was judged to be sufficiently specific to screen the lambda gtll expression library of USDA 110 genomic DNA for the prospective CYPJ12 gene. Library screening for the CYP112 gene. Eight anti-CYP112 antibody-positive clones were selected from the gene library. DNA from one of these clones (Xgtll.108A) (Fig. 2) hybridized with the EcoRI inserts of six of the other clones in a Southern hybridization analysis (data not shown), indicating that all but one of the eight clones were from the same region of DNA. Thus, the EcoRI insert of clone Agtll. 108A was judged to be suitable as a probe for the prospective CYP112 gene from the cosmid library, after it was first subcloned into pUC18. Seven cosmids, each of which shared one or more EcoRI restriction fragments with the others, were identified, and one of these cosmids (cosmid 6A) (Fig. 2) was used for restriction site mapping and subcloning.
Expression of the CYP112 and CYP114 loci in E. coli. A 2.1-kb partial EcoRI fragment from cosmid 6A (Fig. 2) was subcloned into pUC18 downstream of the constitutively expressed lacZ promotor. One clone (pRET61) expressed a polypeptide in host E. coli SE5000 cells that comigrated with authentic CYP112 (Fig. 1A, lane G) . Another clone (pRET60) did not express the polypeptide (Fig. 1A, lane H) and was found by restriction analysis to be in the reverse orientation in pUC18. A spectral analysis of an E. coli soluble extract revealed no active P-450, however (data not shown).
An 8.4-kb EcoRV fragment from cosmid 6A was subcloned into the SmaI site of pUC18. A clone in the forward orientation, as determined by restriction analysis (clone pRET74) (Fig. 2) , was chosen for expression in E. coli DH5a of putative genes downstream of CYP112. Expression of a polypeptide that comigrated with authentic CYP114 was demonstrated by performing a Western blot analysis with anti-CYP114 antibody (Fig. 1B, lane I) ; the results indicated that pRET74 contains the putative CYP114 gene. The product of the CYP112 locus did not react with anti-CYP114 antibody (Fig. 1B, lane G) , and the product of the CYP114 gene did not react with anti-CYP114 antibody (Fig. 1A, lane  I) .
Mutagenesis of the P-450 region and plant tests. In order to disrupt the CYP112 locus and downstream genes, a TnS cassette (a 5.3-kb HpaI fragment from transposon Tn5 encoding Kmr Smr [19] ) was inserted into an EcoRI restriction site in the presumptive CYP112 gene in pRET60. Plasmid pRET60 was partially digested with EcoRI, and the fragments were separated by preparative agarose gel electrophoresis. A partially digested fragment having the mobility expected for a fragment with a single cut (4.8 kb) was isolated (cuts at three EcoRI sites were possible [ Fig. 2]) . The 3' recessed EcoRI termini were filled in by using Klenow fragment DNA polymerase (16) cassette was ligated into the site. Restriction analysis of the resulting clones was used to screen for one clone having an insertion in the desired EcoRI site. The final construction was pRET70 (Fig. 2) . To introduce this mutation into the B. japonicum genome, the 7.4-kb EcoRI insert containing the TnS cassette was excised from pRET70 and ligated into the EcoRI site of broad-host-range suicide vector pSUP202. The resultant plasmid (pRET72) (Fig. 2) (Fig. 1A , lane E) and CYP114 (Fig. 1B, lane E) , but the nodules in the seven jars inoculated with BJ1005 were missing both gene products (Fig. 1A and B, lanes F). This also confirmed that the mutation in CYPJ12 was a polar mutation for CYPJ14. CO difference spectra of soluble extracts of bacteroids confirmed that little or no cytochromes P-450 were present in BJ1005 compared with wild-type USDA 110 (Fig. 3A) , verifying that the TnS cassette insertion was indeed in the correct location in the P-450 locus. CO difference spectra of membrane preparations from the same bacteroids (Fig. 3B) (Fig. 1) revealed the presence of at least two P-450 proteins coded for by genes in cosmid 6A and its subclones (Fig. 2) . Each of the two antibodies was sufficiently specific so that it did not cross-react with the other's antigen (Fig. 1, lanes A and B) , and yet both antibodies reacted with polypeptides from bacteroids and anaerobically grown cells (Fig. 1, lanes F and E, respectively) . The two genes were isolated on subclones pRET61 (gene CYP112) and pRET74 (gene CYP114), as determined by forced expression of the respective polypeptides in E. coli (Fig. 1,  lanes F through I) . The fact that a transposon insertion in the CYP112 region prevented synthesis of any detectable P-450 (Fig. 3) indicates that there are probably no P-450 genes expressed upstream of the putative CYP1J2 gene, although the presence of more downstream genes (besides CYP114), whose products would not be expressed if they are on the same operon because of the polar effect of the TnS cassette insertion, cannot be ruled out on the basis of this evidence.
Expression of spectrally active P-450 from a lacZ promoter in E. coli has been demonstrated for P. putida P450.m (24) . Despite the presence of the polypeptide translation products in the E. coli clones, we observed no spectrally active P-450 in the E. coli extracts (data not shown).
A comparison with the genetic organization of other bacterial cytochrome P-450 loci showed that the closest relative of B. japonicum that contains P-450 (or P-450-like) genes isA. tumefaciens, which has the plant-induciblepinFl and pinF2 genes (11) . It is noteworthy that the two pinF genes occur in tandem on the same transcript, just like the CYPJ12 and CYP114 genes.
Rhizobial P-450s have been observed to occur in both the soluble and membrane fractions of cells (2, 12) . As Fig. 3 shows, the mutation in the CYP112 gene leads to the loss of P-450 in both the soluble and membrane fractions of cells.
Thus, it is likely that the P-450 observed in membrane fractions is soluble P-450 entrained in membrane vesicles.
The lack of a plant phenotype for the mutant strain leads to the conclusion that cytochromes P-450 are not required for nodulation or for symbiotic N2 fixation. This is surprising in light of the presumed role of P-450 in an efficient pathway of oxidative phosphorylation (4, 5, 26) . One possibility is that there is another P-450 present that compensates for the loss of CYP112 and CYP114. However, a spectral analysis of the BJ1005 mutant (Fig. 3) revealed that little or no P-450 was present. A very small amount of P-450 could be masked by the Soret trough of the CO-reactive cytochrome c which is present. Other possibilities are (i) that under the conditions of the plant tests, plant growth and N2 fixation were limited by something other than P-450, so that a P-450-phenotype was not apparent and (ii) that P-450 is involved in a bacteroid function that does not affect the plant, such as viability after nodule senescence.
Cytochromes P-450 are synthesized under low 02 tensions in B. japonicum. The levels of expression of CYPJ12 and CYP114 were higher in bacteroids than in anaerobic nitrategrown cells (Fig. 1, lanes D and E) . Thus, it is possible that some nodule factor in addition to low 02 tension is involved in expression. Future work will involve testing for factors that induce expression of the operon, such as using plant extracts in combination with low 02 tensions. Also, sequencing of the operon will be performed in order to identify other genes that are coexpressed with the P-450 genes. The identification of other genes on the operon will help in elucidating the biochemical pathway in which the P-450s participate. The fact that the genes are expressed under symbiotic conditions strongly suggests that they play a role in some aspect of nodule function or biochemistry, even though a symbiotic phenotype was not apparent under the conditions which we tested.
